New Delhi, Dec. 12 -- The Delhi High Court's division bench on Friday declined to stay a single-judge order that allows Indian drugmaker Dr Reddy's Laboratories to domestically manufacture and export ... Read More
New Delhi, Dec. 11 -- Danish drugmaker Novo Nordisk has moved the Delhi High Court's division bench seeking to restrain Dr Reddy's Laboratories from domestically manufacturing and exporting semaglutid... Read More
New Delhi, Dec. 11 -- Danish drugmaker Novo Nordisk has moved Delhi High Court's division bench seeking to restrain Dr. Reddy's Laboratories from domestically manufacturing and exporting semaglutide-t... Read More
New Delhi, Dec. 9 -- As blockbuster weight loss drug semaglutide inches closer to losing its patent exclusivity in India, innovator Novo Nordisk is upping its ante against local firms wanting to launc... Read More
New Delhi, Dec. 9 -- As blockbuster weight loss drug semaglutide inches closer to losing its patent exclusivity in India, innovator Novo Nordisk is upping its ante against local firms wanting to launc... Read More
New Delhi, Dec. 2 -- The Delhi High Court on Tuesday allowed domestic drugmaker Dr Reddy's Laboratories to manufacture and export its generic version of semaglutide to countries where the patent-holde... Read More
New Delhi, Oct. 17 -- The Supreme Court on Friday rejected Swiss pharmaceutical giant F. Hoffmann-La Roche AG's (Roche) plea seeking that Natco Pharma Ltd be restricted from selling the generic versio... Read More
New Delhi, Oct. 14 -- Swiss drugmaker Roche has moved the Supreme Court, seeking to restrain Natco Pharma from selling the generic version of its life-saving spinal muscular atrophy (SMA) drug Risdipl... Read More
NEW DELHI, Oct. 9 -- The Delhi High Court on Thursday refused to stop Natco Pharma from selling its generic version of Risdiplam, dismissing a plea by F. Hoffmann-La Roche. The Swiss drugmaker market... Read More